Participants:18–64 years · 65+ years
Substances:(S)-N-(5-(4-(1-(Benzo[D][1,3]Dioxol-5-Yl)Ethyl)Piperazin-1-Yl)-1,3,4-Thiadiazol-2-Yl)Acetamide, Hydrochloride Salt

Contact Research Centre

Metachromatic leukodystrophy

Not recruiting

InvestigationalNo placebo

Study of Intrathecal Cebsulfase Alfa for Children with Late Infantile Metachromatic Leukodystrophy

InvestigationalNo placebo

Spain

Participants:0–17 years
Substances:Cebsulfase Alfa

Contact Research Centre

Pancreatitis acute+1

Not recruiting

Registered drug

Study on Simvastatin for Preventing Recurrent Pancreatitis in Patients

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Lactose Monohydrate

Contact Research Centre

Malignant glioma

Not recruiting

Registered drugNo placebo

Study of tovorafenib versus standard chemotherapy as first treatment for children with low-grade glioma with RAF gene changes

Registered drugNo placebo

Spain

Participants:0–17 years · 18–64 years
Substances:Carboplatin

Contact Research Centre

Hodgkin's disease

Not recruiting

Registered drugNo placebo

Title: Comparing Brentuximab Vedotin plus ESHAP versus ESHAP alone in treating patients with relapsed or refractory classical Hodgkin's Lymphoma

Registered drugNo placebo

Spain

Participants:18–64 years
Substances:Brentuximab Vedotin

Contact Research Centre

Endometrial cancer recurrent

Not recruiting

Registered drugNo placebo

Study on Durvalumab, Olaparib, and Chemotherapy for Patients with Advanced or Recurrent Endometrial Cancer in Spain

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Durvalumab

Contact Research Centre

Ischaemic stroke

Not recruiting

Registered drugNo placebo

Study on Blood Pressure Management with Urapidil, Phenylephrine, and Labetalol for Patients with Acute Ischemic Stroke After Endovascular Therapy

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Urapidil

Contact Research Centre

Neuroblastoma

Not recruiting

Registered drugNo placebo

Study on Bevacizumab with Temozolomide and Irinotecan for Children with Relapsed or Refractory Neuroblastoma

Registered drugNo placebo

Spain

Participants:0–17 years
Substances:Bevacizumab

Contact Research Centre

Find therapies in clinical trials near you – page 12

201 trials match your criteria

Squamous cell carcinoma of head and neck

Study on Adding Nivolumab to Cisplatin and Radiotherapy for High-Risk Patients with Head and Neck Squamous Cell Carcinoma

Breast cancer+7

Study of Sacituzumab Govitecan compared to standard therapy in HER2-negative breast cancer patients with high risk of relapse after neoadjuvant treatment

Study on the Safety of TAK-755, Rituximab, and Glucocorticoids for Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura (iTTP)

Study on the Safety of TAK-755, Rituximab, and Glucocorticoids for Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura (iTTP)

Multiple system atrophy

Study on the Effects of TAK-341 for Patients with Multiple System Atrophy

Progressive supranuclear palsy

Study of FNP-223 tablets to slow disease progression in patients with Progressive Supranuclear Palsy (PSP)

Metachromatic leukodystrophy

Study of Intrathecal Cebsulfase Alfa for Children with Late Infantile Metachromatic Leukodystrophy

Pancreatitis acute+1

Study on Simvastatin for Preventing Recurrent Pancreatitis in Patients

Malignant glioma

Study of tovorafenib versus standard chemotherapy as first treatment for children with low-grade glioma with RAF gene changes

Hodgkin's disease

Title: Comparing Brentuximab Vedotin plus ESHAP versus ESHAP alone in treating patients with relapsed or refractory classical Hodgkin's Lymphoma

Endometrial cancer recurrent

Study on Durvalumab, Olaparib, and Chemotherapy for Patients with Advanced or Recurrent Endometrial Cancer in Spain

Ischaemic stroke

Study on Blood Pressure Management with Urapidil, Phenylephrine, and Labetalol for Patients with Acute Ischemic Stroke After Endovascular Therapy

Neuroblastoma

Study on Bevacizumab with Temozolomide and Irinotecan for Children with Relapsed or Refractory Neuroblastoma

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.